SEC Filing

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Filing Date
Jan 17, 2020
Document Date
Jan 17, 2020
Form Description
CORRESP
Filing Group
Other
Company
Jazz Pharmaceuticals plc
Issuer
Jazz Pharmaceuticals plc

Filing Formats